Agenus
Agenus Inc., based in Berkeley, CA, is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop therapies aimed at curing cancer. With a robust pipeline that includes innovative programs targeting both cold and hot tumors, Agenus strives to improve patient outcomes through advanced immuno-oncology solutions.
The company employs a team of experts and leverages partnerships to accelerate the development of its therapeutics, including its lead program, botensilimab, a next-generation CTLA-4 antibody designed for enhanced efficacy and tolerability. Through its commitment to innovation in immunotherapy, Agenus aims to expand the population benefiting from these vital treatments.
Generated from the website
You might also like
Partial Data by Foursquare.
